Figure 1.
Risk classification of patients diagnosed with nonmetastatic invasive hormone receptor-positive human epidermal growth factor receptor 2-negative (HR+/HER2−) breast cancer in the Netherlands between 2011 and 2019.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.